Back to company

PHARMAORIGIN ApS: Financial statements 2021

CVR: 29178291

PHARMAORIGIN ApS (CVR 29178291) has filed annual accounts for 2021. In 2021, the company reported a net result of DKK 40,000 compared with DKK 13,000 the year before. Equity amounted to DKK 1,149,000. The solvency ratio was 99.1%.

Profit/Loss
40,000 kr.
Equity
1,149,000 kr.
Total Assets
1,159,000 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021--40 t.1.1 mio.-
2020--13 t.1.1 mio.-
2019--18 t.1.1 mio.0
2018---23 t.1.1 mio.-
2017---4.3 mio.1.1 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like PHARMAORIGIN ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2021

PHARMAORIGIN ApS: The 2020 annual report is outJun 3, 2021

PHARMAORIGIN ApS has published its annual report for 2020. The net result was DKK 13,000.

About PHARMAORIGIN ApS

PHARMAORIGIN ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2005. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The company was previously named ApS KBUS 17 NR. 4503. The management consists of Danielle Marie Brown. The company is owned by Savara ApS. The company has 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 100,000 compared with DKK 94,000 the year before. Equity amounted to DKK 1,477,000.